Cytoplasmic Immunoreactivity for Thyroid Transcription Factor-1 in Hepatocellular Carcinoma: A Comparative Immunohistochemical Analysis of Four Commercial Antibodies Using A Tissue Array Technique

American Journal of Clinical Pathology

Volumn 121, Issue 3, 2004, Pages 343-349

  Pan, Chin Chen ^a,b   Chen, Paul Chih Hsueh ^a   Tsay, Shyh Haw ^a   Chiang, Hung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Hepatocyte; Immunohistochemistry; Thyroid transcription factor 1

Indexed keywords

8G7G3 1; EDETIC ACID; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8G7G3 1; MONOCLONAL ANTIBODY SC 13040; MONOCLONAL ANTIBODY SPT24; REAGENT; SC 13040; SPT24; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM TUMOR; HEAT INDUCED EPITOPE RETRIEVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CARCINOMA; OVARY MUCINOUS CARCINOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TECHNIQUE; TISSUE ARRAY TECHIQUE;

EID: 1542317503     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/8BM44NK626997DJJ     Document Type: Article

References (15)

1. Bingle CD. Thyroid transcription factor-1. Int J Biochem Cell Biol. 1997;29:1471-1473.
2. Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol. 2000;7:123-127.
3. Ordonez NG. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol. 2000;24:598-606.
4. Bejarano PA, Baughman RP, Biddinger PW, et al. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol. 1996;9:445-452.
5. Bejarano PA, Nikiforov YE, Swenson ES, et al. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Molecul Morphol. 2000;8:189-194.
6. Bejarano PA, Mousavi F. Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity. Arch Pathol Lab Med. 2003;127:193-195.
7. Wieczorek TJ, Pinkus JL, Glickman JN, et al. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol. 2002;118:911-921.
8. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002;26:978-988.
9. Fan Z, Van De RM, Montgomery K, et al. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16:137-144.
10. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol. 1993;143:1050-1054.
11. Hirohashi S, Ishak KG, Kojiro M, et al. Hepatocellular carcinoma. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000. World Health Organization Classification of Tumours.
12. Edmondson H. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462-503.
13. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol. 2003;34:597-604.
14. Holzinger A, Dingle S, Bejarano PA, et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma. 1996;15:49-53.
15. Bubendorf L, Nocito A, Moch H, et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol. 2001;195:72-79.